Predictive Factors Associated with Inappropriate Intravenous Proton Pump Inhibitors Use in Hospitalized Patients: A Case-Control Study
Medicina · 2024
DOI: 10.3390/medicina61010010 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift Medicina, 2024. Verfasst von Niveen Khoury und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy Department, EMMS Nazareth Hospital, Nazareth 16100, Israel. Hauptthemen laut MEDLINE: Proton Pump Inhibitors, Inappropriate Prescribing. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and Objectives: Proton Pump Inhibitors (PPIs) are the most effective agents for treating acid-related gastrointestinal disorders. The prescription of an intravenous (IV) formulation of PPIs has increased dramatically. The aims of this study were to assess the appropriateness of IV PPI use and to define the risk factors and outcomes associated with its inappropriate use. Materials and Methods: A case-control retrospective study included all the hospitalized patients who received IV PPIs was conducted. Patient health records were reviewed, data were collected covering the period of the individual patients’ admission to the hospital until discharge or death, and over the 3-month post-discharge period. The appropriateness of the IV PPI use and the resulting clinical outcomes were analyzed.
Results
Overall, 540 patients were analyzed. Among them, 130/540 (24%) had inappropriate PPI use in terms of indication, dosage, and duration of treatment vs. 410 patients who had appropriate indications. Two parameters were associated with inappropriate use: congestive heart failure (OR 1.77; p = 0.02) and prescription of IV PPIs by surgeons vs. internists (OR 1.53; p = 0.05).
Conclusions
Inappropriate IV PPI use is still common in daily clinical practice. Significant predictors of inappropriate use were the presence of congestive heart failure, elderly age, current use of anticoagulants and antithromotics, and the cases managed by surgeons, naturally due to suspected upper gastrointestinal bleedings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmacy Department, EMMS Nazareth Hospital, Nazareth 16100, Israel.
- Department of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 84105, Israel.
- The Institute of Gastroenterology and Hepatology, Soroka Medical Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 84105, Israel.
- Gastroenterology Department, Shaare Zedek Medical Center, Jerusalem 9103102, Israel.
- Gastroenterology Department, Nazareth Hospital, Nazareth 16100, Israel.
- Gastroenterology Department, Galilee Medical Center, Nahariya 22000, Israel.
ORCID-Profile: Niveen Khoury, David Stepensky, Naim Abu Freha, Tawfik Khoury
Zitieren
APA
Khoury, N., Stepensky, D., Abu Freha, N., Mahamid, M., Khoury, T., & Mari, A. (2024). Predictive Factors Associated with Inappropriate Intravenous Proton Pump Inhibitors Use in Hospitalized Patients: A Case-Control Study. Medicina. https://doi.org/10.3390/medicina61010010
Vancouver
Khoury N, Stepensky D, Abu Freha N, Mahamid M, Khoury T, Mari A. Predictive Factors Associated with Inappropriate Intravenous Proton Pump Inhibitors Use in Hospitalized Patients: A Case-Control Study. Medicina. 2024. doi:10.3390/medicina61010010
BibTeX
@article{Khoury2024,
author = {Khoury, Niveen and Stepensky, David and Abu Freha, Naim and Mahamid, Mahmud and Khoury, Tawfik and Mari, Amir},
title = {Predictive Factors Associated with Inappropriate Intravenous Proton Pump Inhibitors Use in Hospitalized Patients: A Case-Control Study},
journal = {Medicina},
year = {2024},
doi = {10.3390/medicina61010010}
}
EUVIMED